US7601717B2ActiveUtilityPatentIndex 63
Pterin analogs
Est. expiryJan 3, 2028(~1.5 yrs left)· nominal 20-yr term from priority
Inventors:KAKKIS EMIL D
A61P 7/06A61P 9/12A61P 43/00A61P 7/00A61P 9/10A61P 9/02A61P 7/02A61P 9/04A61P 3/06A61P 9/00A61P 25/16A61P 25/24A61P 3/00A61P 3/10A61P 27/02A61P 25/18A61P 25/00A61P 25/14A61K 31/519A61P 13/12Y02A50/30
63
PatentIndex Score
2
Cited by
37
References
5
Claims
Abstract
Disclosed herein are analogs of tetrahydrobiopterin, compositions containing the same, and methods of treating an individual suffering from a condition responsive to tetrahydrobiopterin by administration of the analog. These analogs are contemplated for use wherever tetrahydrobiopterin is currently used to treat conditions responsive to tetrahydrobiopterin therapies.
Claims
exact text as granted — not AI-modified1. A compound having a formula
or a pharmaceutically acceptable salt thereof.
2. A composition comprising a compound of claim 1 and a pharmaceutically acceptable diluent, carrier, or excipient.
3. The composition of claim 2 , wherein the composition is suitable for oral administration.
4. The composition of claim 3 , in the form of a solid.
5. The composition of claim 3 , in the form of a liquid.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.